All articles by GlobalData Healthcare

Reformed pharmaceutical regulation across India’s drug landscape

India has recently introduced two significant reforms to its pharmaceutical regulatory framework that will impact the pricing of essential medicines…
Updated UK guidance for finerenone introduces new treatment for HF patients

The National Institute for Health and Care Excellence (NICE) in the UK recently published new guidance on the usage of…
Repligen’s deal for BioLife Solutions indicates shift to manufacturing integration

In July 2026, Repligen agreed to acquire BioLife Solutions in a deal worth $1.5bn. Repligen’s decision to buy a manufacturer…
FDA approval of mFLUSIVA highlights Moderna’s position in mRNA market

The FDA has approved Moderna’s messenger RNA (mRNA) seasonal influenza vaccine, mFLUSIVA (mRNA-1010), for the prevention of seasonal influenza in…
What will health and social care look like under Andy Burnham?

On Monday 20 July 2026, Andy Burnham officially became the new UK Prime Minister, and the subsequent days have been…

European drug manufacturers under threat from proposed US supply chain bill

Plans to investigate US reliance on overseas pharmaceutical manufacturing and supply chains are set to reveal the country’s reliance on…
Cell and gene therapy manufacturers turn to specialist automation partners

Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.…
Australia approves first-in-class Niktimvo for later-line cGVHD

On 1 May 2026, Specialised Therapeutics’ Niktimvo (axatilimab) was registered in the Australian Register of Therapeutic Goods following priority review…
FDA regenerative medicine approvals show growing momentum

Following several years of limited activity, FDA approvals for regenerative medicines have accelerated, culminating in a record eight approvals in…
Dimerix acquisition of DMX-652 bolsters kidney disease development

Dimerix, a clinical-stage biopharmaceutical company developing kidney disease treatments, recently announced that it had acquired DMX-652 from Mission Therapeutics. The…